Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8078383rdf:typepubmed:Citationlld:pubmed
pubmed-article:8078383lifeskim:mentionsumls-concept:C0034493lld:lifeskim
pubmed-article:8078383lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:8078383lifeskim:mentionsumls-concept:C0507850lld:lifeskim
pubmed-article:8078383lifeskim:mentionsumls-concept:C0162577lld:lifeskim
pubmed-article:8078383lifeskim:mentionsumls-concept:C0019134lld:lifeskim
pubmed-article:8078383lifeskim:mentionsumls-concept:C0332157lld:lifeskim
pubmed-article:8078383lifeskim:mentionsumls-concept:C0302148lld:lifeskim
pubmed-article:8078383lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:8078383lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:8078383lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:8078383lifeskim:mentionsumls-concept:C0205276lld:lifeskim
pubmed-article:8078383lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:8078383lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:8078383lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:8078383lifeskim:mentionsumls-concept:C0086296lld:lifeskim
pubmed-article:8078383lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:8078383lifeskim:mentionsumls-concept:C0185125lld:lifeskim
pubmed-article:8078383lifeskim:mentionsumls-concept:C1704608lld:lifeskim
pubmed-article:8078383lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:8078383lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:8078383lifeskim:mentionsumls-concept:C0699493lld:lifeskim
pubmed-article:8078383pubmed:issue4lld:pubmed
pubmed-article:8078383pubmed:dateCreated1994-10-5lld:pubmed
pubmed-article:8078383pubmed:abstractTextExperimentally, heparin inhibits mechanisms that promote fibrosis, neointimal cellular proliferation, and thrombin bound to fibrin at the surface of intraluminal thrombus, but only in relatively high concentrations. A preliminary hypothesis was tested and confirmed in vitro that initial binding of 3H-heparin to mechanically injured porcine aorta is concentration-dependent over a 1,000-50,000 units/ml range (r = 0.9). The hypothesis was then tested in vitro that thermal exposure during contact of heparin to arterial tissue and to clot would enhance binding of the drug. 3H-heparin binding to clot, whole blood particulates, and washed erythrocytes was markedly enhanced by exposure to temperatures > 70 degrees C. Thermal exposure (80 degrees C x 40 s) also enhanced tissue persistence of the drug within porcine aorta subjected to a shear rate of 1,100(-1) in an annular Baumgartner chamber perfused with normal saline at 37 degrees C for 48 h. Heparin in vitro anticoagulant activity persisted after thermal exposure and binding to tissues. A new method was developed for local application of a heparin film that provides a maximum concentration with a tolerable systemic dose during an angioplasty procedure. In an in vivo rabbit model of mural fibrosis after iliac artery angioplasty, the 1-month mean angiographic luminal diameter loss (23% compared to the acute postangioplasty result by computer image analysis) in response to conventional balloon angioplasty (BA) and laser balloon angioplasty (LBA) was the same (P > 0.05). Local application of a heparin film (3,000 units at a concentration > 100,000 units/g), however, reduced the mean % loss in diameter 1 month after LBA (12%), but not after BA (29%), compared to arteries subjected to angioplasty without local heparin (P < .05). The results are consistent with the hypothesis that thermal energy enhances heparin binding to tissues and that local application of a heparin film favorably modulates arterial luminal responses to LBA, but not to BA, in this animal model.lld:pubmed
pubmed-article:8078383pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8078383pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8078383pubmed:languageenglld:pubmed
pubmed-article:8078383pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8078383pubmed:citationSubsetIMlld:pubmed
pubmed-article:8078383pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8078383pubmed:statusMEDLINElld:pubmed
pubmed-article:8078383pubmed:issn0196-8092lld:pubmed
pubmed-article:8078383pubmed:authorpubmed-author:JanoBBlld:pubmed
pubmed-article:8078383pubmed:authorpubmed-author:SheriffM UMUlld:pubmed
pubmed-article:8078383pubmed:authorpubmed-author:KunduS KSKlld:pubmed
pubmed-article:8078383pubmed:authorpubmed-author:ZhanHHlld:pubmed
pubmed-article:8078383pubmed:authorpubmed-author:SpearsJ RJRlld:pubmed
pubmed-article:8078383pubmed:authorpubmed-author:MakkarRRlld:pubmed
pubmed-article:8078383pubmed:authorpubmed-author:NallamothuNNlld:pubmed
pubmed-article:8078383pubmed:authorpubmed-author:YellayiS SSSlld:pubmed
pubmed-article:8078383pubmed:authorpubmed-author:RizviM AMAlld:pubmed
pubmed-article:8078383pubmed:authorpubmed-author:KhetpalVVlld:pubmed
pubmed-article:8078383pubmed:issnTypePrintlld:pubmed
pubmed-article:8078383pubmed:volume14lld:pubmed
pubmed-article:8078383pubmed:ownerNLMlld:pubmed
pubmed-article:8078383pubmed:authorsCompleteNlld:pubmed
pubmed-article:8078383pubmed:pagination329-46lld:pubmed
pubmed-article:8078383pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:8078383pubmed:meshHeadingpubmed-meshheading:8078383-...lld:pubmed
pubmed-article:8078383pubmed:meshHeadingpubmed-meshheading:8078383-...lld:pubmed
pubmed-article:8078383pubmed:meshHeadingpubmed-meshheading:8078383-...lld:pubmed
pubmed-article:8078383pubmed:meshHeadingpubmed-meshheading:8078383-...lld:pubmed
pubmed-article:8078383pubmed:meshHeadingpubmed-meshheading:8078383-...lld:pubmed
pubmed-article:8078383pubmed:meshHeadingpubmed-meshheading:8078383-...lld:pubmed
pubmed-article:8078383pubmed:meshHeadingpubmed-meshheading:8078383-...lld:pubmed
pubmed-article:8078383pubmed:meshHeadingpubmed-meshheading:8078383-...lld:pubmed
pubmed-article:8078383pubmed:meshHeadingpubmed-meshheading:8078383-...lld:pubmed
pubmed-article:8078383pubmed:meshHeadingpubmed-meshheading:8078383-...lld:pubmed
pubmed-article:8078383pubmed:meshHeadingpubmed-meshheading:8078383-...lld:pubmed
pubmed-article:8078383pubmed:meshHeadingpubmed-meshheading:8078383-...lld:pubmed
pubmed-article:8078383pubmed:meshHeadingpubmed-meshheading:8078383-...lld:pubmed
pubmed-article:8078383pubmed:meshHeadingpubmed-meshheading:8078383-...lld:pubmed
pubmed-article:8078383pubmed:year1994lld:pubmed
pubmed-article:8078383pubmed:articleTitleEffects of thermal exposure on binding of heparin in vitro to the arterial wall and to clot and on the chronic angiographic luminal response to local application of a heparin film during angioplasty in an in vivo rabbit model.lld:pubmed
pubmed-article:8078383pubmed:affiliationDepartment of Medicine, Harper Hospital, Detroit, Michigan.lld:pubmed
pubmed-article:8078383pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8078383pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:8078383pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed